Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

CD8+ T Cell Priming in Established Chronic Viral Infection Preferentially Directs Differentiation of Memory-like Cells for Sustained Immunity.

Snell LM, MacLeod BL, Law JC, Osokine I, Elsaesser HJ, Hezaveh K, Dickson RJ, Gavin MA, Guidos CJ, McGaha TL, Brooks DG.

Immunity. 2018 Oct 16;49(4):678-694.e5. doi: 10.1016/j.immuni.2018.08.002. Epub 2018 Oct 9.

PMID:
30314757
2.

Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa.

Deruaz M, Murooka TT, Ji S, Gavin MA, Vrbanac VD, Lieberman J, Tager AM, Mempel TR, Luster AD.

JCI Insight. 2017 Apr 6;2(7):e88533. doi: 10.1172/jci.insight.88533.

3.

Pillars Article: Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells. Nat. Immunol. 2003. 4: 330-336.

Fontenot JD, Gavin MA, Rudensky AY.

J Immunol. 2017 Feb 1;198(3):986-992. No abstract available.

4.

Evaluation of the performance of Tuberculosis Control Programs in Brazil and Spain: an integrative review of the literature.

Arakawa T, Magnabosco GT, Lopes LM, Arnaez MA, Gavín MA, Gallardo Mdel P, Monroe AA, Villa TC.

Cien Saude Colet. 2015 Dec;20(12):3877-89. doi: 10.1590/1413-812320152012.09382014. Review. English, Portuguese.

5.

Interleukin-21 receptor blockade inhibits secondary humoral responses and halts the progression of preestablished disease in the (NZB × NZW)F1 systemic lupus erythematosus model.

Zhang M, Yu G, Chan B, Pearson JT, Rathanaswami P, Delaney J, Ching Lim A, Babcook J, Hsu H, Gavin MA.

Arthritis Rheumatol. 2015 Oct;67(10):2723-31. doi: 10.1002/art.39233.

6.

Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.

Swanson RM, Gavin MA, Escobar SS, Rottman JB, Lipsky BP, Dube S, Li L, Bigler J, Wolfson M, Arnett HA, Viney JL.

J Immunol. 2013 Mar 1;190(5):2027-35. doi: 10.4049/jimmunol.1201760. Epub 2013 Jan 28.

7.

Invasive pneumococcal disease: association between serotype, clinical presentation and lethality.

Rodríguez MA, González AV, Gavín MA, Martínez FM, Marín NG, Blázquez BR, Moreno JC.

Vaccine. 2011 Aug 5;29(34):5740-6. doi: 10.1016/j.vaccine.2011.05.099. Epub 2011 Jun 15.

PMID:
21683112
8.

G protein-coupled receptor 83 is dispensable for the development and function of regulatory T cells.

Lu LF, Gavin MA, Rasmussen JP, Rudensky AY.

Mol Cell Biol. 2007 Dec;27(23):8065-72. Epub 2007 Sep 24.

9.

Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancer.

van der Vliet HJ, Koon HB, Yue SC, Uzunparmak B, Seery V, Gavin MA, Rudensky AY, Atkins MB, Balk SP, Exley MA.

Clin Cancer Res. 2007 Apr 1;13(7):2100-8. Erratum in: Clin Cancer Res. 2007 Jun 1;13(11):3433. van der Vliet, Hans J J [corrected to van der Vliet, Hans J].

10.

Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY.

Nature. 2007 Feb 22;445(7130):936-40. Epub 2007 Jan 21.

PMID:
17237761
11.

Foxp3-dependent programme of regulatory T-cell differentiation.

Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, Rudensky AY.

Nature. 2007 Feb 15;445(7129):771-5. Epub 2007 Jan 14.

PMID:
17220874
12.

An antigen produced by splicing of noncontiguous peptides in the reverse order.

Warren EH, Vigneron NJ, Gavin MA, Coulie PG, Stroobant V, Dalet A, Tykodi SS, Xuereb SM, Mito JK, Riddell SR, Van den Eynde BJ.

Science. 2006 Sep 8;313(5792):1444-7.

13.

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

Gavin MA, Torgerson TR, Houston E, DeRoos P, Ho WY, Stray-Pedersen A, Ocheltree EL, Greenberg PD, Ochs HD, Rudensky AY.

Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64. Epub 2006 Apr 14. Erratum in: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9373.

14.

A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY.

Nat Immunol. 2005 Nov;6(11):1142-51. Epub 2005 Oct 16. Erratum in: Nat Immunol. 2006 Apr;7(4):427.

PMID:
16227984
15.

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Fontenot JD, Gavin MA, Rudensky AY.

Nat Immunol. 2003 Apr;4(4):330-6. Epub 2003 Mar 3.

PMID:
12612578
16.

Dual TCR T cells: gaining entry into the periphery.

Gavin MA, Rudensky AY.

Nat Immunol. 2002 Feb;3(2):109-10. No abstract available.

PMID:
11812982
17.

Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A.

Nat Immunol. 2002 Jan;3(1):33-41. Epub 2001 Dec 10.

PMID:
11740498
18.
19.

Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones.

Riddell SR, Warren EH, Gavin MA, Akatsuka Y, Lewinsohn D, Mutimer H, Cooper L, Topp MS, Bonini C, Greenberg PD.

Cancer J. 2000 May;6 Suppl 3:S250-8. Review. No abstract available.

PMID:
10874495
20.

The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen.

Warren EH, Gavin MA, Simpson E, Chandler P, Page DC, Disteche C, Stankey KA, Greenberg PD, Riddell SR.

J Immunol. 2000 Mar 1;164(5):2807-14.

Supplemental Content

Loading ...
Support Center